ID

15130

Description

Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial; ODM derived from: https://clinicaltrials.gov/show/NCT02330406

Link

https://clinicaltrials.gov/show/NCT02330406

Keywords

Versions (1)
  1. 5/17/16 5/17/16 -
Uploaded on

May 17, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Dipeptidyl-Peptidase 4 Inhibitors NCT02330406

English

Eligibility Dipeptidyl-Peptidase 4 Inhibitors NCT02330406

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with type 2 diabetes with coronary heart diseases who treated with diet, exercise or antidiabetic medications
Description

Diabetes Mellitus, Non-Insulin-Dependent | Coronary heart disease | Diet therapy | Treated with Exercise | Treated with Antidiabetics

Data type

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0010068
UMLS CUI [3]
C0012159
UMLS CUI [4,1]
C0332293
UMLS CUI [4,2]
C0015259
UMLS CUI [5,1]
C0332293
UMLS CUI [5,2]
C0935929
patients who were treated with statins for 8 weeks or longer
Description

Treated with Hydroxymethylglutaryl-CoA Reductase Inhibitors

Data type

boolean

Alias
UMLS CUI [1,1]
C0332293
UMLS CUI [1,2]
C0360714
patients with low-density lipoprotein cholesterol equal to or greater than 100 mg/dl in the at least two of three measurements after the administration of statins
Description

Low density lipoprotein cholesterol measurement Post Administration Hydroxymethylglutaryl-CoA Reductase Inhibitors

Data type

boolean

Alias
UMLS CUI [1,1]
C0202117
UMLS CUI [1,2]
C0687676
UMLS CUI [1,3]
C1533734
UMLS CUI [1,4]
C0360714
patients with glycerated hemoglobin (hba1c, ngsp) equal to or greater than 6.0 % (7.0
Description

hemoglobin, glycerated | Glycosylated hemoglobin A

Data type

boolean

Alias
UMLS CUI [1]
C0062477
UMLS CUI [2]
C0019018
% if patients were not treated with dipeptidyl-peptidase 4 inhibitors) and lesser than 10.5 %
Description

Treated with Dipeptidyl-Peptidase IV Inhibitors

Data type

boolean

Alias
UMLS CUI [1,1]
C0332293
UMLS CUI [1,2]
C1827106
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with type 1 diabetes
Description

Diabetes Mellitus, Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011854
patients with triglyceride equal to or greater than 400 mg/dl in the previous fasting measuments
Description

Triglycerides measurement Fasting

Data type

boolean

Alias
UMLS CUI [1,1]
C0202236
UMLS CUI [1,2]
C0015663
patients who were received insulin therapy or considered to need insulin therapy
Description

Insulin therapy

Data type

boolean

Alias
UMLS CUI [1]
C0557978
patients with pregnancy, possible pregnancy, or on breast-feeding
Description

Pregnancy | Possible Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0332149
UMLS CUI [2,2]
C0032961
UMLS CUI [3]
C0006147
patients with severe infections, perioperative status, or severe trauma
Description

Infection Severe | Status perioperative | Trauma Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C3714514
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0449438
UMLS CUI [2,2]
C1518988
UMLS CUI [3,1]
C3714660
UMLS CUI [3,2]
C0205082
patients who were received glucagon-like peptide-1receptor agonists, rapid insulin secretagogue, or sodium glucose cotransporter 2 inhibitor
Description

Glucagon-Like Peptide-1 Receptor agonists | Insulin, Rapid-Acting | Sodium-Glucose Cotransporter 2 Inhibitor

Data type

boolean

Alias
UMLS CUI [1,1]
C0378073
UMLS CUI [1,2]
C0243192
UMLS CUI [2]
C0356365
UMLS CUI [3]
C3542461
patients whom physician in charge considered inappropriate for the study
Description

Patient Inappropriate Clinical Trial

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548788
UMLS CUI [1,3]
C0008976
Back to the top of the page

Similar models

Eligibility Dipeptidyl-Peptidase 4 Inhibitors NCT02330406

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Coronary heart disease | Diet therapy | Treated with Exercise | Treated with Antidiabetics
Item
patients with type 2 diabetes with coronary heart diseases who treated with diet, exercise or antidiabetic medications
boolean
C0011860 (UMLS CUI [1])
C0010068 (UMLS CUI [2])
C0012159 (UMLS CUI [3])
C0332293 (UMLS CUI [4,1])
C0015259 (UMLS CUI [4,2])
C0332293 (UMLS CUI [5,1])
C0935929 (UMLS CUI [5,2])
Treated with Hydroxymethylglutaryl-CoA Reductase Inhibitors
Item
patients who were treated with statins for 8 weeks or longer
boolean
C0332293 (UMLS CUI [1,1])
C0360714 (UMLS CUI [1,2])
Low density lipoprotein cholesterol measurement Post Administration Hydroxymethylglutaryl-CoA Reductase Inhibitors
Item
patients with low-density lipoprotein cholesterol equal to or greater than 100 mg/dl in the at least two of three measurements after the administration of statins
boolean
C0202117 (UMLS CUI [1,1])
C0687676 (UMLS CUI [1,2])
C1533734 (UMLS CUI [1,3])
C0360714 (UMLS CUI [1,4])
hemoglobin, glycerated | Glycosylated hemoglobin A
Item
patients with glycerated hemoglobin (hba1c, ngsp) equal to or greater than 6.0 % (7.0
boolean
C0062477 (UMLS CUI [1])
C0019018 (UMLS CUI [2])
Treated with Dipeptidyl-Peptidase IV Inhibitors
Item
% if patients were not treated with dipeptidyl-peptidase 4 inhibitors) and lesser than 10.5 %
boolean
C0332293 (UMLS CUI [1,1])
C1827106 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
patients with type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Triglycerides measurement Fasting
Item
patients with triglyceride equal to or greater than 400 mg/dl in the previous fasting measuments
boolean
C0202236 (UMLS CUI [1,1])
C0015663 (UMLS CUI [1,2])
Insulin therapy
Item
patients who were received insulin therapy or considered to need insulin therapy
boolean
C0557978 (UMLS CUI [1])
Pregnancy | Possible Pregnancy | Breast Feeding
Item
patients with pregnancy, possible pregnancy, or on breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0332149 (UMLS CUI [2,1])
C0032961 (UMLS CUI [2,2])
C0006147 (UMLS CUI [3])
Infection Severe | Status perioperative | Trauma Severe
Item
patients with severe infections, perioperative status, or severe trauma
boolean
C3714514 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0449438 (UMLS CUI [2,1])
C1518988 (UMLS CUI [2,2])
C3714660 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Glucagon-Like Peptide-1 Receptor agonists | Insulin, Rapid-Acting | Sodium-Glucose Cotransporter 2 Inhibitor
Item
patients who were received glucagon-like peptide-1receptor agonists, rapid insulin secretagogue, or sodium glucose cotransporter 2 inhibitor
boolean
C0378073 (UMLS CUI [1,1])
C0243192 (UMLS CUI [1,2])
C0356365 (UMLS CUI [2])
C3542461 (UMLS CUI [3])
Patient Inappropriate Clinical Trial
Item
patients whom physician in charge considered inappropriate for the study
boolean
C0030705 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial